drugset / Trial / NCT06760481
Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
RandomizedSingle-groupOpen-labelTreatment
Summary
An open-label, Phase I/Ib study investigating the safety and efficacy of tiragolumab + atezolizumab + RadScopal™ XRT in patients with metastatic solid malignancies.
Timeline
- Start
- 2025-04-13
- Primary completion
- 2028-09-15
- Completion
- 2030-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tiragolumab | Monoclonal antibody | — | Intravenous |
| Background | Atezolizumab | Monoclonal antibody | — | Intravenous |